Amlodipine Management in Hypotension and Renal Impairment

Hypotension Parameters

The European Society of Cardiology recommends holding amlodipine in patients with symptomatic hypotension or severe asymptomatic hypotension (systolic blood pressure <90 mmHg) 1
Consider dose reduction if patient has no symptoms or signs of congestion but experiences dizziness/light-headedness, as suggested by the European Journal of Heart Failure 1
Reconsider the need for other vasodilators (nitrates, other calcium channel blockers) when hypotension occurs, according to the European Journal of Heart Failure 3

Amlodipine should be used with caution in patients with significant renal dysfunction (creatinine >221 μmol/L [>2.5 mg/dL] or eGFR <30 mL/min/1.73 m²), as recommended by the European Society of Cardiology 1, 2
Monitor renal function before initiation and periodically during treatment, as advised by the British Journal of Pharmacology 4, 5

Check renal function and electrolytes before initiating amlodipine, as recommended by the European Society of Cardiology 2
Re-check blood chemistry 1-2 weeks after initiation and after any increase in dose, according to the European Society of Cardiology 2
Monitor blood chemistry every 4 months thereafter, as suggested by the European Society of Cardiology 2
Pay particular attention to potassium levels when combining with ACE inhibitors or ARBs, as recommended by the British Journal of Pharmacology 4

Amlodipine may actually have renoprotective effects in patients with renal impairment, especially when paired with ARBs, as suggested by the British Journal of Pharmacology 4
Be cautious when combining amlodipine with other medications that affect the renin-angiotensin-aldosterone system in patients with renal impairment, as advised by the British Journal of Pharmacology 6

If systolic BP <90 mmHg and patient is symptomatic: Hold amlodipine, as recommended by the European Society of Cardiology 1
If systolic BP <90 mmHg but patient is asymptomatic: Consider dose reduction, according to the European Society of Cardiology 1
For patients with renal impairment: Use with caution, consider lower doses if creatinine >221 μmol/L or eGFR <30 mL/min/1.73 m², as recommended by the European Society of Cardiology 1, 2

Be cautious when combining amlodipine with other medications that affect the renin-angiotensin-aldosterone system in patients with renal impairment, as advised by the Praxis Medical Insights 6
Don't overlook the need for more frequent monitoring when initiating therapy or changing doses in patients with renal dysfunction, as recommended by the British Journal of Pharmacology and the European Society of Cardiology 4, 2